A detailed history of Brown Advisory Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Brown Advisory Inc holds 90,000 shares of OCUL stock, worth $708,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,000
Previous 90,000 -0.0%
Holding current value
$708,300
Previous $615,000 27.15%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

BUY
$15.82 - $22.11 $1.42 Million - $1.99 Million
90,000 New
90,000 $1.48 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $606M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.